Steven Rosenberg (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Steven Rosenberg" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

18^th place

17^th place

low place

low place

7^th place

7^th place

low place

low place

1achievement.org

1,925^th place

1,057^th place

low place

low place

1marketscreener.com

7,438^th place

5,529^th place

low place

low place

1dandavidprize.org

low place

low place

low place

9,476^th place

1web.archive.org

1^st place

1^st place

achievement.org

"Golden Plate Awardees of the American Academy of Achievement". www.achievement.org. American Academy of Achievement.

amc.edu

"Trailblazing Researchers in Immunotherapy Selected to Receive Americas Most Distinguished Prize in Medicine". www.amc.edu.

ascopost.com

"Steven A. Rosenberg Works to Unmask Cancer's Achilles Heel - the ASCO Post".

clarivate.com

"Citation Laureates 2023_Physiology or Medicine". Citation Laureates. Clarivate. Archived from the original on September 19, 2023. Retrieved September 19, 2023.

dandavidprize.org

Dan David Prize 2021

doi.org

Wrangle, JM; Patterson, A; Johnson, CB; Neitzke, DJ; Mehrotra, S; Denlinger, CE; Paulos, CM; Li, Z; Cole, DJ; Rubinstein, MP (February 2018). "IL-2 and Beyond in Cancer Immunotherapy". Journal of Interferon & Cytokine Research. 38 (2): 45–68. doi:10.1089/jir.2017.0101. PMC 5815463. PMID 29443657.
Dudley ME, Wunderlich JR, Robbins PF, et al. (October 2002). "Cancer regression and autoimmunity in patients after clonal re-population with antitumor lymphocytes". Science. 298 (5594): 850–4. Bibcode:2002Sci...298..850D. doi:10.1126/science.1076514. PMC 1764179. PMID 12242449.
Morgan RA, Dudley ME, Wunderlich JR, et al. (October 2006). "Cancer regression in patients after transfer of genetically engineered lymphocytes". Science. 314 (5796): 126–9. Bibcode:2006Sci...314..126M. doi:10.1126/science.1129003. PMC 2267026. PMID 16946036.
Jaffee EM, Hruban RH, Biedrzycki B, et al. (January 2001). "Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation". Journal of Clinical Oncology. 19 (1): 145–56. doi:10.1200/jco.2001.19.1.145. PMID 11134207.

harvard.edu

ui.adsabs.harvard.edu

Dudley ME, Wunderlich JR, Robbins PF, et al. (October 2002). "Cancer regression and autoimmunity in patients after clonal re-population with antitumor lymphocytes". Science. 298 (5594): 850–4. Bibcode:2002Sci...298..850D. doi:10.1126/science.1076514. PMC 1764179. PMID 12242449.
Morgan RA, Dudley ME, Wunderlich JR, et al. (October 2006). "Cancer regression in patients after transfer of genetically engineered lymphocytes". Science. 314 (5796): 126–9. Bibcode:2006Sci...314..126M. doi:10.1126/science.1129003. PMC 2267026. PMID 16946036.

jco.org

Jaffee EM, Hruban RH, Biedrzycki B, et al. (January 2001). "Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation". Journal of Clinical Oncology. 19 (1): 145–56. doi:10.1200/jco.2001.19.1.145. PMID 11134207.

marketscreener.com

"2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy". www.marketscreener.com. 15 August 2019.

nfcr.org

"Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research". National Foundation for Cancer Research. 12 February 2019. Retrieved 24 February 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wrangle, JM; Patterson, A; Johnson, CB; Neitzke, DJ; Mehrotra, S; Denlinger, CE; Paulos, CM; Li, Z; Cole, DJ; Rubinstein, MP (February 2018). "IL-2 and Beyond in Cancer Immunotherapy". Journal of Interferon & Cytokine Research. 38 (2): 45–68. doi:10.1089/jir.2017.0101. PMC 5815463. PMID 29443657.
Dudley ME, Wunderlich JR, Robbins PF, et al. (October 2002). "Cancer regression and autoimmunity in patients after clonal re-population with antitumor lymphocytes". Science. 298 (5594): 850–4. Bibcode:2002Sci...298..850D. doi:10.1126/science.1076514. PMC 1764179. PMID 12242449.
Morgan RA, Dudley ME, Wunderlich JR, et al. (October 2006). "Cancer regression in patients after transfer of genetically engineered lymphocytes". Science. 314 (5796): 126–9. Bibcode:2006Sci...314..126M. doi:10.1126/science.1129003. PMC 2267026. PMID 16946036.
Jaffee EM, Hruban RH, Biedrzycki B, et al. (January 2001). "Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation". Journal of Clinical Oncology. 19 (1): 145–56. doi:10.1200/jco.2001.19.1.145. PMID 11134207.

ncbi.nlm.nih.gov

Wrangle, JM; Patterson, A; Johnson, CB; Neitzke, DJ; Mehrotra, S; Denlinger, CE; Paulos, CM; Li, Z; Cole, DJ; Rubinstein, MP (February 2018). "IL-2 and Beyond in Cancer Immunotherapy". Journal of Interferon & Cytokine Research. 38 (2): 45–68. doi:10.1089/jir.2017.0101. PMC 5815463. PMID 29443657.
Dudley ME, Wunderlich JR, Robbins PF, et al. (October 2002). "Cancer regression and autoimmunity in patients after clonal re-population with antitumor lymphocytes". Science. 298 (5594): 850–4. Bibcode:2002Sci...298..850D. doi:10.1126/science.1076514. PMC 1764179. PMID 12242449.
Morgan RA, Dudley ME, Wunderlich JR, et al. (October 2006). "Cancer regression in patients after transfer of genetically engineered lymphocytes". Science. 314 (5796): 126–9. Bibcode:2006Sci...314..126M. doi:10.1126/science.1129003. PMC 2267026. PMID 16946036.

nih.gov

"NIH immunotherapy pioneer Steven Rosenberg awarded nation's highest honor for technology and innovation". National Institutes of Health (NIH). 2023-10-24. Retrieved 2023-10-24.

nytimes.com

Pollack, Andrew (August 1, 2016). "Setting the Body's 'Serial Killers' Loose on Cancer (Published 2016)". The New York Times.

web.archive.org

"Citation Laureates 2023_Physiology or Medicine". Citation Laureates. Clarivate. Archived from the original on September 19, 2023. Retrieved September 19, 2023.